115 related articles for article (PubMed ID: 10698114)
1. Characterization of C-terminal-truncated urinary metabolites of a recombinant hirudin in rats.
Komatsu Y; Hayashi H
Peptides; 1999 Dec; 20(12):1401-9. PubMed ID: 10698114
[TBL] [Abstract][Full Text] [Related]
2. C-terminal proteolytic degradation of recombinant desulfato-hirudin and its mutants in the yeast Saccharomyces cerevisiae.
Heim J; Takabayashi K; Meyhack B; Märki W; Pohlig G
Eur J Biochem; 1994 Dec; 226(2):341-53. PubMed ID: 8001551
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the postglomerular renal metabolism of lepirudin in healthy volunteers.
Kautzleben M; Stein G; Sperschneider H; Nowak G
Thromb Res; 2004; 113(3-4):187-95. PubMed ID: 15140582
[TBL] [Abstract][Full Text] [Related]
4. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
Komatsu Y; Inoue Y; Goto Y; Fukazawa T; Hayashi H
Thromb Haemost; 1999 Feb; 81(2):250-5. PubMed ID: 10064001
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the identity of hirudin isolated after kidney passage with the starting material.
Henschen A; Markwardt F; Walsmann P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):59-63. PubMed ID: 2459033
[TBL] [Abstract][Full Text] [Related]
7. Purification and identification of recombinant hirudin and its degradation products expressed in Pichia pastoris.
Zhou WB; Zhang YX
Prep Biochem Biotechnol; 2004 Aug; 34(3):239-52. PubMed ID: 15461140
[TBL] [Abstract][Full Text] [Related]
8. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the structural elements of hirudin C-terminal peptide that bind to the fibrinogen recognition site of alpha-thrombin.
Chang JY
Biochemistry; 1991 Jul; 30(27):6656-61. PubMed ID: 2065053
[TBL] [Abstract][Full Text] [Related]
10. Nuclear magnetic resonance solution structure of hirudin(1-51) and comparison with corresponding three-dimensional structures determined using the complete 65-residue hirudin polypeptide chain.
Szyperski T; Güntert P; Stone SR; Wüthrich K
J Mol Biol; 1992 Dec; 228(4):1193-205. PubMed ID: 1335515
[TBL] [Abstract][Full Text] [Related]
11. Preparation of dextran-bound recombinant hirudin and its pharmacokinetic behaviour.
Markwardt F; Richter M; Walsmann P; Riesener G; Paintz M
Biomed Biochim Acta; 1990; 49(10):1103-8. PubMed ID: 1706917
[TBL] [Abstract][Full Text] [Related]
12. Hirudin and hirudin-based peptides.
Stone SR; Maraganore JM
Methods Enzymol; 1993; 223():312-36. PubMed ID: 8271960
[No Abstract] [Full Text] [Related]
13. Anti-hirudin monoclonal antibodies directed toward discontinuous epitopes of the hirudin amino-terminal and epitopes involving the carboxy-terminal hirudin amino acids.
Koch C; Whitechurch O; Cordier P; Roitsch C
Anal Biochem; 1993 Oct; 214(1):301-12. PubMed ID: 7504411
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic investigation of hirudin binding to the slow and fast forms of thrombin: evidence for folding transitions in the inhibitor and protease coupled to binding.
Ayala YM; Vindigni A; Nayal M; Spolar RS; Record MT; Di Cera E
J Mol Biol; 1995 Nov; 253(5):787-98. PubMed ID: 7473752
[TBL] [Abstract][Full Text] [Related]
15. Reevaluating the effects of tyrosine iodination of recombinant hirudin on its thrombin inhibition kinetics.
Komatsu Y; Hayashi H
Thromb Res; 1997 Aug; 87(4):343-52. PubMed ID: 9271811
[TBL] [Abstract][Full Text] [Related]
16. Existence of beta-methylnorleucine in recombinant hirudin produced by Escherichia coli.
Muramatsu R; Negishi T; Mimoto T; Miura A; Misawa S; Hayashi H
J Biotechnol; 2002 Feb; 93(2):131-42. PubMed ID: 11738720
[TBL] [Abstract][Full Text] [Related]
17. Positional effects of sulfation in hirudin and hirudin PA related anticoagulant peptides.
Payne MH; Krstenansky JL; Yates MT; Mao SJ
J Med Chem; 1991 Mar; 34(3):1184-7. PubMed ID: 2002458
[TBL] [Abstract][Full Text] [Related]
18. The structural elements of hirudin which bind to the fibrinogen recognition site of thrombin are exclusively located within its acidic C-terminal tail.
Chang JY; Ngai PK; Rink H; Dennis S; Schlaeppi JM
FEBS Lett; 1990 Feb; 261(2):287-90. PubMed ID: 2107100
[TBL] [Abstract][Full Text] [Related]
19. Probing the structure of hirudin from Hirudinaria manillensis by limited proteolysis. Isolation, characterization and thrombin-inhibitory properties of N-terminal fragments.
Vindigni A; De Filippis V; Zanotti G; Visco C; Orsini G; Fontana A
Eur J Biochem; 1994 Dec; 226(2):323-33. PubMed ID: 8001550
[TBL] [Abstract][Full Text] [Related]
20. Biophysical studies of interactions of hirudin analogs with bovine and human thrombin by ESR and fluorescence labelling studies.
Berliner LJ; Woodford JK
Adv Exp Med Biol; 1993; 340():51-65. PubMed ID: 8154343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
